- Home
- MED vs AVTX Comparison
MED vs AVTX Comparison
Compare MED & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MED
- AVTX
- Stock Information
- Founded
- MED 1980
- AVTX 2011
- Country
- MED United States
- AVTX United States
- Employees
- MED N/A
- AVTX N/A
- Industry
- MED Packaged Foods
- AVTX Biotechnology: Pharmaceutical Preparations
- Sector
- MED Consumer Staples
- AVTX Health Care
- Exchange
- MED Nasdaq
- AVTX Nasdaq
- Market Cap
- MED 152.3M
- AVTX 138.8M
- IPO Year
- MED N/A
- AVTX 2015
- Fundamental
- Price
- MED $13.68
- AVTX $11.60
- Analyst Decision
- MED Hold
- AVTX Strong Buy
- Analyst Count
- MED 1
- AVTX 8
- Target Price
- MED $16.50
- AVTX $31.00
- AVG Volume (30 Days)
- MED 166.4K
- AVTX 230.1K
- Earning Date
- MED 11-03-2025
- AVTX 11-06-2025
- Dividend Yield
- MED N/A
- AVTX N/A
- EPS Growth
- MED N/A
- AVTX N/A
- EPS
- MED 0.33
- AVTX N/A
- Revenue
- MED $480,449,000.00
- AVTX $441,000.00
- Revenue This Year
- MED N/A
- AVTX N/A
- Revenue Next Year
- MED N/A
- AVTX N/A
- P/E Ratio
- MED $41.07
- AVTX N/A
- Revenue Growth
- MED N/A
- AVTX N/A
- 52 Week Low
- MED $11.57
- AVTX $3.39
- 52 Week High
- MED $21.98
- AVTX $16.00
- Technical
- Relative Strength Index (RSI)
- MED 47.90
- AVTX 74.04
- Support Level
- MED $13.71
- AVTX $8.65
- Resistance Level
- MED $14.24
- AVTX $12.41
- Average True Range (ATR)
- MED 0.48
- AVTX 0.86
- MACD
- MED -0.01
- AVTX 0.11
- Stochastic Oscillator
- MED 27.14
- AVTX 81.00
About MED MEDIFAST INC
Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. OPTAVIA provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. Medifast remains committed to its mission of offering Lifelong Transformation, Making a Healthy Lifestyle Second Nature.
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).